SUBSCRIBE
SUBSCRIBE
News   Deals

Astellas Pharma Inc. Extends OSI Pharmaceuticals, Inc. Offer, Again

April 23, 2010 | 
1 min read
Reuters -- OSI Pharmaceuticals Inc, which has been fending off a hostile takeover bid by Japan's Astellas Pharma Inc, reported much lower first quarter profit on Thursday as results were hit by costs associated with the tender offer.
Mergers & acquisitions
Astellas Pharma US, Inc.
MORE ON THIS TOPIC
Podcast
Sentiment at BIO soars as FDA resets, dealmaking evolves; Amgen’s Tavneos in hot water
July 1, 2026
 · 
2 min read
 · 
Jef Akst
Upward arrow on the background of the flag of China. Paper plane. Economic recovery. Copy space. Business. Background.
China
Deerfield bets up to $1.6B to snag autoimmune asset in China for Boulevard
June 30, 2026
 · 
1 min read
 · 
Annalee Armstrong
Solution Concept with Handshake on Chalkboard Background
Mergers & acquisitions
Zymeworks adds lung disease drug, royalty deals in nearly $1B pick up of Theravance
June 29, 2026
 · 
2 min read
 · 
Annalee Armstrong
Business handshake trendy halftone art collage banner template. Partnership concept, successful agreement, closing a deal, securing a contract. Modern retro cut out vector illustration
Mergers & acquisitions
Ipsen makes up to $1.75B blood cancer bet with Kartos buyout
June 29, 2026
 · 
2 min read
 · 
Tristan Manalac